Filing Details
- Accession Number:
- 0001127602-21-028376
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-04 15:36:51
- Reporting Period:
- 2021-11-02
- Accepted Time:
- 2021-11-04 15:36:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1287981 | Jed John Kennedy | C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773 | Group Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-02 | 862 | $41.93 | 8,237 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-02 | 862 | $146.67 | 7,375 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-02 | 5,100 | $59.96 | 12,475 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-02 | 1,822 | $147.06 | 10,653 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-02 | 3,278 | $147.57 | 7,375 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-02 | 1,800 | $78.76 | 9,175 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-02 | 928 | $147.51 | 8,247 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-02 | 872 | $148.31 | 7,375 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-02 | 1,700 | $97.69 | 9,075 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-02 | 1,700 | $148.60 | 7,375 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-02 | 862 | $0.00 | 862 | $41.93 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-02 | 5,100 | $0.00 | 5,100 | $59.96 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-02 | 1,800 | $0.00 | 1,800 | $78.76 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-02 | 1,700 | $0.00 | 1,700 | $97.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2027-03-01 | No | 4 | M | Direct | |
| 10,800 | 2028-03-01 | No | 4 | M | Direct | |
| 5,700 | 2029-03-01 | No | 4 | M | Direct | |
| 7,600 | 2030-03-02 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
